Blue Ridge Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-563,800
| Closed | -$51.2M | – | 42 |
|
|
2017
Q2 | $51.2M | Sell |
563,800
-31,200
| -5% | -$2.83M | 0.9% | 35 |
|
|
2017
Q1 | $52.2M | Hold |
595,000
| – | – | 0.68% | 37 |
|
|
2016
Q4 | $49.3M | Sell |
595,000
-205,000
| -26% | -$17M | 0.62% | 40 |
|
|
2016
Q3 | $74M | Hold |
800,000
| – | – | 0.88% | 35 |
|
|
2016
Q2 | $62.2M | Sell |
800,000
-200,000
| -20% | -$15.6M | 0.8% | 37 |
|
|
2016
Q1 | $82.5M | Sell |
1,000,000
-540,000
| -35% | -$44.5M | 1% | 34 |
|
|
2015
Q4 | $161M | Hold |
1,540,000
| – | – | 1.8% | 28 |
|
|
2015
Q3 | $162M | Sell |
1,540,000
-580,000
| -27% | -$61.1M | 1.87% | 26 |
|
|
2015
Q2 | $290M | Sell |
2,120,000
-110,000
| -5% | -$15M | 3.27% | 10 |
|
|
2015
Q1 | $278M | Hold |
2,230,000
| – | – | 3.17% | 10 |
|
|
2014
Q4 | $202M | Hold |
2,230,000
| – | – | 2.45% | 17 |
|
|
2014
Q3 | $161M | Buy |
2,230,000
+130,000
| +6% | +$9.38M | 1.9% | 26 |
|
|
2014
Q2 | $131K | Buy |
2,100,000
+40,000
| +2% | +$2.49K | 1.29% | 32 |
|
|
2014
Q1 | $141M | Hold |
2,060,000
| – | – | 1.55% | 30 |
|
|
2013
Q4 | $145M | Buy |
2,060,000
+310,000
| +18% | +$21.8M | 1.49% | 30 |
|
|
2013
Q3 | $126M | Hold |
1,750,000
| – | – | 1.51% | 30 |
|
|
2013
Q2 | $97.5M | Buy |
+1,750,000
| New | +$97.5M | 1.18% | 37 |
|